Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : YEEHAW CANDIDATES -- Ignore unavailable to you. Want to Upgrade?

To: J.F. who wrote (18983)	9/6/2006 12:15:51 PM
From: Galirayo	Read Replies (2) \| Respond to of 23958

BIOTECH STOCKS Drug stocks dip, Genta halted PrintE-mailDisable live quotesRSSDigg itDel.icio.usBy Val Brickates Kennedy, MarketWatch Last Update: 10:39 AM ET Sep 6, 2006 BOSTON (MarketWatch) -- Drug stocks dipped in early trading Wednesday as shares of Genta were halted pending the outcome of a Food and Drug Administration advisory panel hearing on its oncology drug candidate Genasense. 09/06/2006 marketwatch.com GNTA0.86, -0.53, -38.2%) was halted at 86 cents, the day after it tumbled almost 40% on concerns that an FDA advisory panel would not recommend Genasense be approved for the treatment of chronic lymphocytic leukemia. Genasense is Genta's lead product candidate.